394
Participants
Start Date
October 22, 2021
Primary Completion Date
February 5, 2025
Study Completion Date
March 31, 2026
Brodalumab
Brodalumab
Matched cohort
Matched cohort
CARE Site 42, Calgary
CARE Site 26, Calgary
CARE Site 15, Calgary
CARE Site 18, Edmonton
CARE Site 41, Edmonton
CARE Site 21, Edmonton
CARE Site 37, Edmonton
CARE Site 28, Sherwood Park
CARE Site 31, Vancouver
CARE Site 36, Winnipeg
CARE Site 12, Winnipeg
CARE Site 35, Saint Johns
CARE Site 11, Ajax
CARE Site 05, Barrie
CARE Site 06, Greater Sudbury
CARE Site 20, Guelph
CARE Site 14, Hamilton
CARE Site 24, Hamilton
CARE Site 23, London
CARE Site 22, London
CARE Site 09, London
CARE Site 33, Markham
CARE Site 44, Mississauga
CARE Site 51, Niagara Falls
CARE Site 48, North York
CARE Site 27, Oshawa
CARE Site 13, Richmond Hill
CARE Site 49, Toronto
CARE Site 16, Toronto
CARE Site 32, Whitby
CARE Site 38, Drummondville
CARE Site 07, Laval
CARE Site 50, Laval
CARE Site 04, Montreal
CARE Site 46, Québec
CARE Site 30, Québec
CARE Site 17, Québec
CARE Site 52, Saint-Charles-Borromée
CARE Site 39, Saint-Jérôme
CARE Site 47, Sherbrooke
CARE Site 40, Westmount
CARE Site 03, Saskatoon
Bausch Health Americas, Inc.
INDUSTRY